Intragastric Balloon (BIB system) in the treatment of obesity and preparation of patients for surgery - own experience and literature review
- PMID: 22166356
- DOI: 10.2478/v10035-011-0028-2
Intragastric Balloon (BIB system) in the treatment of obesity and preparation of patients for surgery - own experience and literature review
Abstract
Despite the recognition of bariatric surgery as the only effective method of weight reduction, we remain in search of minimally invasive methods, both for the treatment of obesity and preparation of patients for surgical procedures. The aim of the study was to determine intragastric balloon (Allergan) implantation results as the only method of treating obesity, and patient preparation for further stages of abdominal hernia operations, as well as other surgical procedures.
Material and methods: The study presented own results considering the use of Bioenteric Intragastric Balloons (BIB system) in the treatment of pathological obesity, and preparation of patients for bariatric surgery and abdominal hernia operations. The study group comprised 18 female and 7 male patients. Average patient age amounted to 50.6 and 54 years, respectively. Indications for intragastric balloon insertion were as follows: preparation for hernia (10 cases) and bariatric (5 patients) operations, and weight reduction management (8 patients). In two cases the implantation of the intragastric balloon served the preparation for gynecological and orthopedic (vertebral column) operations. One female patient was prepared for both bariatric and hernial surgery. The procedure was performed under general anesthesia. Statistical analysis considered 22 patients (one female patient was excluded from analysis, due to death, two other were excluded because of lack of sufficient data).Results. In case of two patients the intragastric balloon system was removed before 6 months had elapsed because of intolerance. One female patient died during the observation period for reasons not related to the procedure. The obtained BMI reduction ranged between 2 and 6 kg/m2, which amounted to a maximum weight loss of 24 kg. In one patient a weight gain of 2 kg was observed. Considering patients prepared for abdominal hernia operations weight reduction was greater and better maintained after the removal of the BIB system.
Conclusions: According to the authors of the presented study the intragastric balloon serves its role as a bridge to bariatric procedures and weight reduction, before planned extensive postoperative hernia operations. The use of the intragastric balloon only to reduce weight has no medical and economic justification.
Similar articles
-
The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients.Singapore Med J. 2007 Mar;48(3):227-31. Singapore Med J. 2007. PMID: 17342292
-
The intragastric balloon - smoothing the path to bariatric surgery.Obes Surg. 2006 Jul;16(7):897-902. doi: 10.1381/096089206777822188. Obes Surg. 2006. PMID: 16839490
-
Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy.Obes Surg. 2005 Jan;15(1):101-5. doi: 10.1381/0960892052993558. Obes Surg. 2005. PMID: 15760507
-
Position of intragastric balloons in global initiative for obesity treatment.Coll Antropol. 2011 Dec;35(4):1353-62. Coll Antropol. 2011. PMID: 22397287 Review.
-
Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases.Surg Obes Relat Dis. 2018 Feb;14(2):151-159. doi: 10.1016/j.soard.2017.09.528. Epub 2017 Sep 28. Surg Obes Relat Dis. 2018. PMID: 29108896 Review.
Cited by
-
Endoscopic Bariatric Therapies.Curr Gastroenterol Rep. 2016 Jun;18(6):26. doi: 10.1007/s11894-016-0501-5. Curr Gastroenterol Rep. 2016. PMID: 27098813 Review.
-
Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay.Surg Endosc. 2020 Jun;34(6):2519-2531. doi: 10.1007/s00464-019-07061-w. Epub 2019 Aug 9. Surg Endosc. 2020. PMID: 31399943 Clinical Trial.
-
In search of the ideal patient for the intragastric balloon - short- and long-term results in 70 obese patients.Wideochir Inne Tech Maloinwazyjne. 2016 Jan;10(4):541-7. doi: 10.5114/wiitm.2015.55748. Epub 2015 Nov 23. Wideochir Inne Tech Maloinwazyjne. 2016. PMID: 26865890 Free PMC article.
-
Impact of preoperative weight loss achieved by gastric balloon on peri- and postoperative outcomes of bariatric surgery in super-obese patients: a retrospective matched-pair analysis.Langenbecks Arch Surg. 2022 Aug;407(5):1873-1879. doi: 10.1007/s00423-022-02472-1. Epub 2022 Mar 8. Langenbecks Arch Surg. 2022. PMID: 35257223 Free PMC article.
-
Abdominal Morphologic Changes in MRI during Gastric Balloon Therapy.Obes Facts. 2022;15(5):703-710. doi: 10.1159/000526444. Epub 2022 Aug 16. Obes Facts. 2022. PMID: 35973414 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical